Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... Read More
Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safet... Read More
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07772102) titled 'TelesDystocia: Tele-Support vs. Cognitive Aid in Simulated Shoulder Dystocia' on July 31. ... Read More
Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safet... Read More
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07772544) titled 'Prevention of Psoriatic Arthritis Inflammation Through Digital Care: A Feasibility Mixed-Me... Read More
Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) M... Read More
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07772999) titled 'Effect of Comic-Based Education on Attitudes Toward Patient Rights' on Aug. 14. Brief Summ... Read More
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07772375) titled '225 IU Versus 300 IU Starting FSH Dose in PPOS for Good-Prognosis Women' on Aug. 13. Brief... Read More
Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig i... Read More
Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and ... Read More